SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC) -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (76)7/20/2000 12:09:52 PM
From: reno21  Read Replies (1) | Respond to of 724
 
test



To: scaram(o)uche who wrote (76)7/20/2000 6:48:20 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 724
 
Another company that is profiting from "genomics trickle down", one of my favorite instrumentation providers. Sales for this quarter were approx. 2X NBSC sales for last quarter, at 62% margin. Market cap is approx. 900M, or about 18X that of NBSC.........

Thursday July 20, 4:30 pm Eastern Time

Company Press Release

SOURCE: Molecular Devices Corporation

Molecular Devices Reports Record Revenues and
Earnings for Second Quarter And First Half of 2000

SUNNYVALE, Calif., July 20 /PRNewswire/ -- Molecular Devices Corporation (Nasdaq: MDCC - news) today announced
record revenues and earnings for the second quarter and first half of 2000.

Revenues for the second quarter were $20,307,000, higher than any previous quarter in the Company's history and a 37%
increase over sales reported in the same period last year. Revenues for the first six months of the year were $37,375,000, or an
increase of 32% compared to the same period of 1999.

Operating income increased 38% in the second quarter and first six months of the year as compared to operating income in the
same periods last year (excluding the effect of a $2,037,000 write-off of acquired in-process research and development
recorded in the second quarter of 1999). (snip)